The test screens for genetic variations in enzymes that influences how the patient’s metabolism will process opioids. Physicians can use this information to adjust dosages and predict side effects.
More Articles on Pain Management:
Georgia’s Houston Medical Center May Expand Pain Clinic
DEA Schedules September National Prescription Drug Take-Back Day
New York Pain Consultants Partner With Medtronic on Physician Training
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
